First-in-human trial of a novel suprachoroidal retinal prosthesis.

Retinal visual prostheses ("bionic eyes") have the potential to restore vision to blind or profoundly vision-impaired patients. The medical bionic technology used to design, manufacture and implant such prostheses is still in its relative infancy, with various technologies and surgical app...

Full description

Bibliographic Details
Main Authors: Lauren N Ayton, Peter J Blamey, Robyn H Guymer, Chi D Luu, David A X Nayagam, Nicholas C Sinclair, Mohit N Shivdasani, Jonathan Yeoh, Mark F McCombe, Robert J Briggs, Nicholas L Opie, Joel Villalobos, Peter N Dimitrov, Mary Varsamidis, Matthew A Petoe, Chris D McCarthy, Janine G Walker, Nick Barnes, Anthony N Burkitt, Chris E Williams, Robert K Shepherd, Penelope J Allen, Bionic Vision Australia Research Consortium
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4270734?pdf=render
_version_ 1819086602170793984
author Lauren N Ayton
Peter J Blamey
Robyn H Guymer
Chi D Luu
David A X Nayagam
Nicholas C Sinclair
Mohit N Shivdasani
Jonathan Yeoh
Mark F McCombe
Robert J Briggs
Nicholas L Opie
Joel Villalobos
Peter N Dimitrov
Mary Varsamidis
Matthew A Petoe
Chris D McCarthy
Janine G Walker
Nick Barnes
Anthony N Burkitt
Chris E Williams
Robert K Shepherd
Penelope J Allen
Bionic Vision Australia Research Consortium
author_facet Lauren N Ayton
Peter J Blamey
Robyn H Guymer
Chi D Luu
David A X Nayagam
Nicholas C Sinclair
Mohit N Shivdasani
Jonathan Yeoh
Mark F McCombe
Robert J Briggs
Nicholas L Opie
Joel Villalobos
Peter N Dimitrov
Mary Varsamidis
Matthew A Petoe
Chris D McCarthy
Janine G Walker
Nick Barnes
Anthony N Burkitt
Chris E Williams
Robert K Shepherd
Penelope J Allen
Bionic Vision Australia Research Consortium
author_sort Lauren N Ayton
collection DOAJ
description Retinal visual prostheses ("bionic eyes") have the potential to restore vision to blind or profoundly vision-impaired patients. The medical bionic technology used to design, manufacture and implant such prostheses is still in its relative infancy, with various technologies and surgical approaches being evaluated. We hypothesised that a suprachoroidal implant location (between the sclera and choroid of the eye) would provide significant surgical and safety benefits for patients, allowing them to maintain preoperative residual vision as well as gaining prosthetic vision input from the device. This report details the first-in-human Phase 1 trial to investigate the use of retinal implants in the suprachoroidal space in three human subjects with end-stage retinitis pigmentosa. The success of the suprachoroidal surgical approach and its associated safety benefits, coupled with twelve-month post-operative efficacy data, holds promise for the field of vision restoration.Clinicaltrials.gov NCT01603576.
first_indexed 2024-12-21T21:22:51Z
format Article
id doaj.art-b9cb3c37192546c5b6a4c81a3d6f7157
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-21T21:22:51Z
publishDate 2014-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-b9cb3c37192546c5b6a4c81a3d6f71572022-12-21T18:49:51ZengPublic Library of Science (PLoS)PLoS ONE1932-62032014-01-01912e11523910.1371/journal.pone.0115239First-in-human trial of a novel suprachoroidal retinal prosthesis.Lauren N AytonPeter J BlameyRobyn H GuymerChi D LuuDavid A X NayagamNicholas C SinclairMohit N ShivdasaniJonathan YeohMark F McCombeRobert J BriggsNicholas L OpieJoel VillalobosPeter N DimitrovMary VarsamidisMatthew A PetoeChris D McCarthyJanine G WalkerNick BarnesAnthony N BurkittChris E WilliamsRobert K ShepherdPenelope J AllenBionic Vision Australia Research ConsortiumRetinal visual prostheses ("bionic eyes") have the potential to restore vision to blind or profoundly vision-impaired patients. The medical bionic technology used to design, manufacture and implant such prostheses is still in its relative infancy, with various technologies and surgical approaches being evaluated. We hypothesised that a suprachoroidal implant location (between the sclera and choroid of the eye) would provide significant surgical and safety benefits for patients, allowing them to maintain preoperative residual vision as well as gaining prosthetic vision input from the device. This report details the first-in-human Phase 1 trial to investigate the use of retinal implants in the suprachoroidal space in three human subjects with end-stage retinitis pigmentosa. The success of the suprachoroidal surgical approach and its associated safety benefits, coupled with twelve-month post-operative efficacy data, holds promise for the field of vision restoration.Clinicaltrials.gov NCT01603576.http://europepmc.org/articles/PMC4270734?pdf=render
spellingShingle Lauren N Ayton
Peter J Blamey
Robyn H Guymer
Chi D Luu
David A X Nayagam
Nicholas C Sinclair
Mohit N Shivdasani
Jonathan Yeoh
Mark F McCombe
Robert J Briggs
Nicholas L Opie
Joel Villalobos
Peter N Dimitrov
Mary Varsamidis
Matthew A Petoe
Chris D McCarthy
Janine G Walker
Nick Barnes
Anthony N Burkitt
Chris E Williams
Robert K Shepherd
Penelope J Allen
Bionic Vision Australia Research Consortium
First-in-human trial of a novel suprachoroidal retinal prosthesis.
PLoS ONE
title First-in-human trial of a novel suprachoroidal retinal prosthesis.
title_full First-in-human trial of a novel suprachoroidal retinal prosthesis.
title_fullStr First-in-human trial of a novel suprachoroidal retinal prosthesis.
title_full_unstemmed First-in-human trial of a novel suprachoroidal retinal prosthesis.
title_short First-in-human trial of a novel suprachoroidal retinal prosthesis.
title_sort first in human trial of a novel suprachoroidal retinal prosthesis
url http://europepmc.org/articles/PMC4270734?pdf=render
work_keys_str_mv AT laurennayton firstinhumantrialofanovelsuprachoroidalretinalprosthesis
AT peterjblamey firstinhumantrialofanovelsuprachoroidalretinalprosthesis
AT robynhguymer firstinhumantrialofanovelsuprachoroidalretinalprosthesis
AT chidluu firstinhumantrialofanovelsuprachoroidalretinalprosthesis
AT davidaxnayagam firstinhumantrialofanovelsuprachoroidalretinalprosthesis
AT nicholascsinclair firstinhumantrialofanovelsuprachoroidalretinalprosthesis
AT mohitnshivdasani firstinhumantrialofanovelsuprachoroidalretinalprosthesis
AT jonathanyeoh firstinhumantrialofanovelsuprachoroidalretinalprosthesis
AT markfmccombe firstinhumantrialofanovelsuprachoroidalretinalprosthesis
AT robertjbriggs firstinhumantrialofanovelsuprachoroidalretinalprosthesis
AT nicholaslopie firstinhumantrialofanovelsuprachoroidalretinalprosthesis
AT joelvillalobos firstinhumantrialofanovelsuprachoroidalretinalprosthesis
AT peterndimitrov firstinhumantrialofanovelsuprachoroidalretinalprosthesis
AT maryvarsamidis firstinhumantrialofanovelsuprachoroidalretinalprosthesis
AT matthewapetoe firstinhumantrialofanovelsuprachoroidalretinalprosthesis
AT chrisdmccarthy firstinhumantrialofanovelsuprachoroidalretinalprosthesis
AT janinegwalker firstinhumantrialofanovelsuprachoroidalretinalprosthesis
AT nickbarnes firstinhumantrialofanovelsuprachoroidalretinalprosthesis
AT anthonynburkitt firstinhumantrialofanovelsuprachoroidalretinalprosthesis
AT chrisewilliams firstinhumantrialofanovelsuprachoroidalretinalprosthesis
AT robertkshepherd firstinhumantrialofanovelsuprachoroidalretinalprosthesis
AT penelopejallen firstinhumantrialofanovelsuprachoroidalretinalprosthesis
AT bionicvisionaustraliaresearchconsortium firstinhumantrialofanovelsuprachoroidalretinalprosthesis